We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Parliament Passes Pharmacovigilance Requirement to Report Adverse Reactions
EU Parliament Passes Pharmacovigilance Requirement to Report Adverse Reactions
October 14, 2010
Drugmakers and competent authorities would, for the first time, be required to report all adverse drug reactions — not just serious ones — to the EudraVigilance database, according to new pharmacovigilance legislation adopted Sept. 22 by the European Parliament.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor